The DOI matches its Crossref record; 293 of the 293 references it cites were found in a registry or an index.
Melatonin: Nature’s most versatile biological signal?
Open accessAbstract
Melatonin is a ubiquitous molecule and widely distributed in nature, with functional activity occurring in unicellular organisms, plants, fungi and animals. In most vertebrates, including humans, melatonin is synthesized primarily in the pineal gland and is regulated by the environmental light/dark cycle via the suprachiasmatic nucleus. Pinealocytes function as 'neuroendocrine transducers' to secrete melatonin during the dark phase of the light/dark cycle and, consequently, melatonin is often called the 'hormone of darkness'. Melatonin is principally secreted at night and is centrally involved in sleep regulation, as well as in a number of other cyclical bodily activities. Melatonin is exclusively involved in signaling the 'time of day' and 'time of year' (hence considered to help both clock and calendar functions) to all tissues and is thus considered to be the body's chronological pacemaker or 'Zeitgeber'. Synthesis of melatonin also occurs in other areas of the body, including the retina, the gastrointestinal tract, skin, bone marrow and in lymphocytes, from which it may influence other physiological functions through paracrine signaling. Melatonin has also been extracted from the seeds and leaves of a number of plants and its concentration in some of this material is several orders of magnitude higher than its night-time plasma value in humans. Melatonin participates in diverse physiological functions. In addition to its timekeeping functions, melatonin is an effective antioxidant which scavenges free radicals and up-regulates several antioxidant enzymes. It also has a strong antiapoptotic signaling function, an effect which it exerts even during ischemia. Melatonin's cytoprotective properties have practical implications in the treatment of neurodegenerative diseases. Melatonin also has immune-enhancing and oncostatic properties. Its 'chronobiotic' properties have been shown to have value in treating various circadian rhythm sleep disorders, such as jet lag or shift-work sleep disorder. Melatonin acting as an 'internal sleep facilitator' promotes sleep, and melatonin's sleep-facilitating properties have been found to be useful for treating insomnia symptoms in elderly and depressive patients. A recently introduced melatonin analog, agomelatine, is also efficient for the treatment of major depressive disorder and bipolar affective disorder. Melatonin's role as a 'photoperiodic molecule' in seasonal reproduction has been established in photoperiodic species, although its regulatory influence in humans remains under investigation. Taken together, this evidence implicates melatonin in a broad range of effects with a significant regulatory influence over many of the body's physiological functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Children typically produce more melatonin than adults, which may infer that their need for dietary supplementation may require further scrutiny and be limited to specific disease states [4,11].”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [4]
In the citing paper
“Production gradually declines as people age, starting in the late twenties to the fifties, with production leveling at approximately 30 pg/mL [4,11] (see Figure 1).”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [4]
In the citing paper
“Aside from aging, production of melatonin can be influenced by illness [12], diet [4], environmental factors like bright light at night [13], medication use [14], and lifestyle [15].”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [4]
In the citing paper
“Melatonin is colloquially referred to as the “hormone of darkness” since it is produced in response to darkness, as perceived by the eye’s retina [4].”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phototransduction by retinal ganglion cells that set the circadian clock
Berson, D. M., Dunn, F. A., & Takao, M. (2002) · Science · doi:10.1126/science.1067262 · Cited by 3,629
Regulation of antioxidant enzymes: a significant role for melatonin
Rodrı́guez, C., Mayo, J. C., Sainz, R. M., Antolı́n, I., Herrera, F., Martı́n, V., & Reiter, R. J. (2003) · Journal of Pineal Research · doi:10.1046/j.1600-079x.2003.00092.x · Cited by 1,990
Neurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor
Brainard, G. C., Hanifin, J. P., Greeson, J. M., Byrne, B., Glickman, G., Gerner, E., & Rollag, M. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06405.2001 · Cited by 1,930
Mortality Associated With Sleep Duration and Insomnia
Kripke, D. F., Garfinkel, L., Wingard, D. L., Klauber, M. R., & Marler, M. R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.2.131 · Cited by 1,614
The Pineal and Its Hormones in the Control of Reproduction in Mammals*
Reiter, R. J. (1980) · Endocrine Reviews · doi:10.1210/edrv-1-2-109 · Cited by 1,254
Reppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096
Tan, D., Reiter, R. J., Manchester, L. C., Yan, M.-T., El-Sawi, M. R., Sainz, R. M., Mayo, J. C., Kohen, R., Allegra, M., & Hardelan, R. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023394443 · Cited by 1,065
The melatonin rhythm: both a clock and a calendar
Reiter, R. J. (1993) · Cellular and Molecular Life Sciences · doi:10.1007/bf01923947 · Cited by 997
The basic physiology and pathophysiology of melatonin
Claustrat, B., Brun, J., & Chazot, G. (2004) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.08.001 · Cited by 951
Research works printed but not linked: 8
- Hardeland R, 1996, Metabolism and Cellular Dynamics of Indoles, 6
- Dubocovich ML, 2000, The IUPHAR Compendium of Receptor Characterization and Classification, 271
- 10.1007/BF03033887 · DOI
- 10.1016/j.exger.2005.08.009 · DOI
- Olie P, 2005, Confirmed clinical efficacy of agomelatine (25–50 mg) in major depression; two randomized, double‐blind controlled studies, Eur Neuropsychopharmacol, 15, S416
- 10.1097/00007632-200303150-00008 · DOI
- 10.1034/j.1600-079X.2001.300105.x · DOI
- 10.1210/jc.86.1.129 · DOI · Paper page
Cited by
Sorted by citations
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D. X., Sainz, R. M., Alatorre-Jiménez, M. A., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,777
Melatonin as a natural ally against oxidative stress: a physicochemical examination
Galano, A., Tan, D. X., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00916.x · Cited by 1,167
Melatonin—A pleiotropic, orchestrating regulator molecule
Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843
Self-citationMelatonin: Pharmacology, Functions and Therapeutic Benefits
Tordjman, S., Sylvie Chokron, A., Delorme, R., Charrier, A., Bellissant, É., Jaafari, N., & Fougerou, C. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161228122115 · Cited by 879
Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
Pandi-Perumal, S. R., Trakht, I. N., SRINIVASAN, V., SPENCE, D., Maestroni, G. J. M., Zisapel, N., & Cardinali, D. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.001 · Cited by 799
Self-citationAmide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 692
Circadian genes, rhythms and the biology of mood disorders
McClung, C. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.003 · Cited by 666
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Lemaître, B. J., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 617
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-19683-6 · Cited by 505
Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
Reiter, R. J., Paredes, S. D., Manchester, L. C., & Tan, D.-X. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230903044914 · Cited by 483
Hardeland, R., Tan, D., & Reiter, R. J. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00701.x · Cited by 477
Self-citationThe Glymphatic System: A Novel Component of Fundamental Neurobiology
Hablitz, L. M., & Nedergaard, M. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0619-21.2021 · Cited by 503
Involvement of ROS in BBB dysfunction
Pun, P. B. L., Lu, J., & Moochhala, S. (2009) · Free Radical Research · doi:10.1080/10715760902751902 · Cited by 469
Melatonin and inflammation-Story of a double-edged blade
Hardeland, R. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12525 · Cited by 455
Self-citationMelatonin, sleep disturbance and cancer risk
Blask, D. E. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2008.07.007 · Cited by 465
Hardeland, R., Madrid, J. A., Tan, D. X., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00934.x · Cited by 457
Self-citationTan, D. X., Hardeland, R., Manchester, L. C., Paredes, S. D., Korkmaz, A., Sainz, R. M., Mayo, J. C., Fuentes‐Broto, L., & Reiter, R. J. (2009) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2009.00118.x · Cited by 365
Self-citationAging, melatonin, and the pro- and anti-inflammatory networks
Hardeland, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051223 · Cited by 337
Self-citationMelatonin in the skin: synthesis, metabolism and functions
Slominski, A. T., Tobin, D. J., Zmijewski, M. A., Wortsman, J., & Paus, R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.10.007 · Cited by 342
Clarifying the role of sleep in depression: A narrative review
Pandi-Perumal, S. R., Monti, J. M., Burman, D., Ramanujam, K., BaHammam, A. S., Spence, D. W., Brown, G. M., & Narashimhan, M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113239 · Cited by 351
Self-citationPandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320
Self-citationCircadian photoreception: ageing and the eye's important role in systemic health
Turner, P. L., & Mainster, M. A. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.141747 · Cited by 315
Thidiazuron: A multi-dimensional plant growth regulator
Guo, B., Abbasi, B. H., Amir, Z., L, L. X., & Y, H. W. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.636 · Cited by 302
Tarocco, A., Caroccia, N., Morciano, G., Wieckowski, M. R., Ancora, G., Garani, G., & Pinton, P. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1556-7 · Cited by 307
Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions
Slominski, A. T., Hardeland, R., Zmijewski, M. A., Slominski, R. M., Reiter, R. J., & Paus, R. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.025 · Cited by 314
Self-citationMeli, R., Monnolo, A., Annunziata, C., Pirozzi, C., & Ferrante, M. C. (2020) · Antioxidants · doi:10.3390/antiox9050405 · Cited by 305
Circadian rhythms and memory formation
Gerstner, J. R., & Yin, J. C. P. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2881 · Cited by 260
Hardeland, R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8001-x · Cited by 253
Self-citationBarik, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228776 · Cited by 233
Melatonin as an anti-inflammatory agent modulating inflammasome activation
Favero, G., Franceschetti, L., Bonomini, F., Rodella, L. F., & Rezzani, R. (2017) · International Journal of Endocrinology · doi:10.1155/2017/1835195 · Cited by 233
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
Jung-Hynes, B. D., Reiter, R. J., & Ahmad, N. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00729.x · Cited by 237
Melatonin: Signaling mechanisms of a pleiotropic agent
Hardeland, R. (2009) · BioFactors · doi:10.1002/biof.23 · Cited by 227
Self-citationMelatonin Mitigates Salt Stress in Wheat Seedlings by Modulating Polyamine Metabolism
Ke, Q., Ye, J., Wang, B., Ren, J., Yin, L., Deng, X., & Wang, S. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00914 · Cited by 228
Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment
Yıldız, E. P., Ekici, B., & Tatlı, B. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1259567 · Cited by 220
Paus, R., Schallreuter, K. U., Bahadoran, P., Picardo, M., Slominski, A. T., Elassiuty, Y. E., Kemp, E. H., Giachino, C., Liu, J. B., Luiten, R. M., et al. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00666_1.x · Cited by 216
Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
Talib, W. H., Alsayed, A. R., Abuawad, A., Daoud, S., & Mahmod, A. I. (2021) · Molecules · doi:10.3390/molecules26092506 · Cited by 235
Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms
Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Trakht, I., & Cardinali, D. P. (2008) · Integrative Cancer Therapies · doi:10.1177/1534735408322846 · Cited by 208
Self-citationMelatonin: functions and ligands
Singh, M., & Jadhav, H. R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.04.014 · Cited by 206
Hardeland, R. (2012) · Europe PMC (PubMed Central) · Cited by 203
Self-citationImplications of circadian clocks for the rhythmic delivery of cancer therapeutics
Lévi, F., Focan, C., Karaboué, A., de la Valette, V., Focan-Henrard, D., Baron, B., Kreutz, F., & Giacchetti, S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.11.001 · Cited by 199
Gottlieb, J. F., Benedetti, F., Geoffroy, P. A., Henriksen, T. E. G., Lam, R. W., Murray, G., Phelps, J., Sit, D., Swartz, H. A., Crowe, M., et al. (2019) · Bipolar Disorders · doi:10.1111/bdi.12847 · Cited by 196
Vasiliou, V., & Gonzalez, F. J. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.061807.154729 · Cited by 193
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair
Fischer, T. W., Slominski, A. T., Zmijewski, M. A., Reiter, R. J., & Paus, R. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00767.x · Cited by 192
The role of environmental light in sleep and health: Effects of ocular aging and cataract surgery
Turner, P. L., Someren, E. J. W. V., & Mainster, M. A. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.11.002 · Cited by 190
Melatonin in macrophage biology: Current understanding and future perspectives
Xia, Y., Chen, S., Zeng, S., Zhao, Y., Zhu, C., Deng, B., Zhu, G., Yin, Y., Wang, W., Hardeland, R., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12547 · Cited by 191
Self-citationTalaz, O., Gülçın, İ., Göksu, S., & Saraçoğlu, N. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.077 · Cited by 180
Circadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications
Gnocchi, D., & Bruscalupi, G. (2017) · Biology · doi:10.3390/biology6010010 · Cited by 193
Role of the Melatonin System in the Control of Sleep
Pandi-Perumal, S. R., Srinivasan, V., Spence, D. W., & Cardinali, D. P. (2007) · CNS Drugs · doi:10.2165/00023210-200721120-00004 · Cited by 180
Self-citationMelatonin in Medicinal and Food Plants: Occurrence, Bioavailability, and Health Potential for Humans
Salehi, B., Sharopov, F. S., Fokou, P. V. T., Kobylińska, A., de Jonge, L., Tadio, K., Sharifi‐Rad, J., Posmyk, M. M., Martorell, M., Martins, N. A., et al. (2019) · Cells · doi:10.3390/cells8070681 · Cited by 189
MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
Zlotos, D. P., Jockers, R., Cecon, E., Rivara, S., & Witt‐Enderby, P. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401343c · Cited by 179
Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176
“Production gradually declines as people age, starting in the late twenties to the fifties, with production leveling at approximately 30 pg/mL [4,11] (see Figure 1).”
BackgroundInfluentialDominoni, D. M., Goymann, W., Helm, B., & Partecke, J. (2013) · Frontiers in Zoology · doi:10.1186/1742-9994-10-60 · Cited by 177
Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction
Hardeland, R. (2012) · The Scientific World Journal · doi:10.1100/2012/640389 · Cited by 173
Self-citationBedrosian, T. A., Fonken, L. K., Walton, J. C., Haim, A., & Nelson, R. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.01.004 · Cited by 167
Zhang, S., Zheng, X., Reiter, R. J., Feng, S., Wang, Y., Liu, S., Liang, J. H., Li, Z., Datla, R. S. S., & Ren, M. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01993 · Cited by 167
Genetics of circadian rhythms and mood spectrum disorders
Étain, B., Milhiet, V., Bellivier, F., & Leboyer, M. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.007 · Cited by 162
Carloni, S., Perrone, S., Buonocore, G., Longini, M., Proietti, F., & Balduini, W. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00503.x · Cited by 161
Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action
Srinivasan, V., Pandi-Perumal, S. R., Trahkt, I., Spence, D. W., Pöeggeler, B., Hardeland, R., & Cardinali, D. P. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802328607 · Cited by 162
Self-citationFernández‐Bachiller, M. I., Pérez, C., Campillo, N. E., Paez, J. A., González-Muñoz, G. C., Usán, P., García‐Palomero, E., López, M. G., Villarroya, M., Garcı́a, A. G., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200800414 · Cited by 160
New perspectives in melatonin uses
Carpentieri, A. R., de Barboza, G. D., Areco, V. A., López, M. P., & de Talamoni, N. T. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.01.003 · Cited by 158
New targets for rapid antidepressant action
Machado‐Vieira, R., Henter, I. D., & Zarate, C. A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.001 · Cited by 161
Environmental effects on asexual reproduction rates of the scyphozoan Aurelia labiata
Purcell, J. (2007) · Marine Ecology Progress Series · doi:10.3354/meps07056 · Cited by 153
Melatonin in fruit production and postharvest preservation: A review
Wang, S., Shi, X., Wang, R., Wang, H., Liu, F., & Laborda, P. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.126642 · Cited by 151
Antioxidant Activities of Synthetic Indole Derivatives and Possible Activity Mechanisms
Süzen, S. (2007) · Springer eBooks · doi:10.1007/7081_2007_074 · Cited by 151
Nduhirabandi, F., Toit, E. F. D., Blackhurst, D., MARAIS, D. P., & Lochner, A. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00826.x · Cited by 144
Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression
Won, E., Na, K., & Kim, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010305 · Cited by 149
Joo, S. S., & Yoo, Y. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00682.x · Cited by 141
Melatonin increases cleavage rate of porcine preimplantation embryos in vitro
Rodríguez‐Osorio, N., Kim, I. J., Wang, H., Kaya, A., & Memili, E. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00475.x · Cited by 141
Disruption of Circadian Rhythms: A Crucial Factor in the Etiology of Depression
Salgado‐Delgado, R., Osorio, A. T., Saderi, N., & Escobar, C. (2011) · Depression Research and Treatment · doi:10.1155/2011/839743 · Cited by 148
The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140
Antidepressant-like effects of melatonin in the mouse chronic mild stress model
Detanico, B. C., Piato, Â., de Freitas, J. J., Lhullier, F. L. R., Hidalgo, M. P. L., Caumo, W., & Elisabetsky, E. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.02.037 · Cited by 143
Melatonin Metabolism in the Central Nervous System
Hardeland, R. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246164 · Cited by 138
Self-citationFielding a current idea: exploring the public health impact of electromagnetic radiation
Genuis, S. J. (2007) · Public Health · doi:10.1016/j.puhe.2007.04.008 · Cited by 137
A role for the circadian genes in drug addiction
Falcón, E., & McClung, C. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.054 · Cited by 135
Goldman, S. E., Adkins, K. W., Calcutt, M. W., Carter, M. D., Goodpaster, R. L., Wang, L., Shi, Y., Burgess, H. J., Hachey, D. L., & Malow, B. A. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2123-9 · Cited by 133
Othman, A. I., Edrees, G., El-Missiry, M. A., Ali, D. A., Abouel-Nour, M. F., & Dabdoub, B. R. (2014) · Toxicology and Industrial Health · doi:10.1177/0748233714561286 · Cited by 132
Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs
Srinivasan, V., Singh, J., Pandi-Perumal, S. R., Brown, G. M., Spence, D. W., & Cardinali, D. P. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0065-y · Cited by 129
Self-citationBiological rhythms and chronotherapeutics in depression
Geoffroy, P. A., & Palagini, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110158 · Cited by 127
Melatonin the "light of night" in human biology and adolescent idiopathic scoliosis
Grivas, T. B., & Savvidou, O. D. (2007) · Scoliosis · doi:10.1186/1748-7161-2-6 · Cited by 126
Fernando, H. A., Chin, H.-F., Ton, S. H., & Kadir, K. A. (2013) · Journal of Diabetes Research · doi:10.1155/2013/190395 · Cited by 125
Age-related changes in melatonin synthesis in rat extrapineal tissues
Sánchéz‐Hidalgo, M., Alarcón‐de‐la‐Lastra, C., Carrascosa-Salmoral, M. P., Naranjo, M. C., Gómez-Corvera, A., Caballero, B., & Guerrero, J. M. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.02.002 · Cited by 126
Antioxidant Properties of Melatonin and its Potential Action in Diseases
Karaaslan, Ç., & Süzen, S. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150220120946 · Cited by 125
Melatonin in Antinociception: Its Therapeutic Applications
Srinivasan, V., Lauterbach, E. C., Ho, K. Y., Acuña-Castroviejo, D., Zakaria, R., & Brzezinski, A. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604489 · Cited by 123
Self-citationEvidence for the Benefits of Melatonin in Cardiovascular Disease
Tobeiha, M., Jafari, A., Fadaei, S., Mirazimi, S. M. A., Dashti, F., Amiri, A., Khan, H. Z., Asemi, Z., Reiter, R. J., Hamblin, M. R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.888319 · Cited by 126
Melatonin and breast cancer: Evidences from preclinical and human studies
Kubatka, P., Žúbor, P., Büsselberg, D., Kwon, T. K., Adamek, M., Petrovič, D., Opatřilová, R., Gazdíková, K., Čaprnda, M., Rodrigo, L., et al. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.018 · Cited by 125
Obayashi, K., Saeki, K., Iwamoto, J., Okamoto, N., Tomioka, K., Nezu, S., Ikada, Y., & Kurumatani, N. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1873 · Cited by 120
Romo‐Nava, F., Álvarez-Icaza, D., Fresán, A., Saracco-Álvarez, R. A., Becerra‐Palars, C., Moreno, J., Uribe, M. P. O., Berlanga, C., Heinze, G., & Buijs, R. M. (2014) · Bipolar Disorders · doi:10.1111/bdi.12196 · Cited by 122
San, L., & Arranz, B. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.04.002 · Cited by 121
Plasma melatonin is reduced in Huntington's disease
Kalliolia, E., Silajdžić, E., Nambron, R., Hill, N. R., Doshi, A., Frost, C. D., Watt, H., Hindmarsh, P. C., Björkqvist, M., & Warner, T. T. (2014) · Movement Disorders · doi:10.1002/mds.26003 · Cited by 118
Nduhirabandi, F., Toit, E. F. D., & Lochner, A. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02410.x · Cited by 116
Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism
Gnocchi, D., Pedrelli, M., Hurt-Camejo, E., & Parini, P. (2015) · Biology · doi:10.3390/biology4010104 · Cited by 115
Morvaridzadeh, M., Sadeghi, E., Agah, S., Nachvak, S. M., Fazelian, S., Moradi, F., Persad, E., & Heshmati, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105210 · Cited by 115
Hernández, I. G., Gómez, F. J. V., Cerutti, S. E., Arana, M. V., & Silva, M. F. (2015) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2015.06.011 · Cited by 115
Srinivasan, V., Cardinali, D. P., Srinivasan, U. S., Kaur, C., Brown, G. M., Spence, D. W., Hardeland, R., & Pandi-Perumal, S. R. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611406166 · Cited by 116
Self-citationSoliman, A., Lacasse, A., Lanoix, D., Sagrillo‐Fagundes, L., Boulard, V., & Vaillancourt, C. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12236 · Cited by 114
Fogueri, U. R., Kozuch, S., Karton, A., & Martin, J. M. L. (2013) · The Journal of Physical Chemistry A · doi:10.1021/jp312644t · Cited by 115
Melatonin and human reproduction: Shedding light on the darkness hormone
Srinivasan, V., Spence, W., Pandi-Perumal, S. R., Zakharia, R., Bhatnagar, K. P., & Brzezinski, A. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903159649 · Cited by 114
Self-citationMelatonin, Immune Function and Cancer
Srinivasan, V., Pandi-Perumal, S. R., Brzezinski, A., Bhatnagar, K. P., & Cardinali, D. P. (2011) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221411799015408 · Cited by 110
Self-citationHPLC‐F analysis of melatonin and resveratrol isomers in wine using an SPE procedure
Mercolini, L., Saracino, M. A., Bugamelli, F., Ferranti, A., Malaguti, M., Hrelia, S., & Raggi, M. A. (2008) · Journal of Separation Science · doi:10.1002/jssc.200700458 · Cited by 108
Slats, D., Claassen, J. A. H. R., Verbeek, M. M., & Overeem, S. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.04.003 · Cited by 114
Metadata
- Authors
- Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R.
- Affiliations
- Universiti Sains Malaysia (MY)
- Istituto Cantonale di Patologia (CH)
- Universidad de Buenos Aires (AR)
- University of Göttingen (DE)
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2006-06-15
- Volume
- 273
- Issue
- 13
- Pages
- 2813-2838
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2049985521
- Cited by
- 875
- References
- 293
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 33 · 2023: 33 · 2022: 42 · 2021: 56 · 2020: 47 · 2019: 49 · 2018: 42 · 2017: 45 · 2016: 34 · 2015: 38 · 2014: 53 · 2013: 53 · 2012: 51
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Journal (publishedVersion)
- PubMed (publishedVersion)
- GRO (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Physical Sciences › Environmental Science › Global and Planetary Change › Impact of Light on Environment and Health
- Keywords
- melatonin, pineal gland, suprachiasmatic nucleus, circadian rhythm, sleep regulation, antioxidant activity, anti-apoptotic signaling, neuroprotection, neurodegenerative diseases, immunomodulation, circadian rhythm sleep disorders, jet lag, shift work disorder, insomnia, agomelatine, photoperiodism, seasonal reproduction, melatonin analogues
- MeSH terms
- Animals, Antioxidants, Chronobiology Phenomena, Depression, Humans, Melatonin, Models, Chemical, Plant Proteins, Sleep, Signal Transduction, Free Radical Scavengers, Apoptosis, Receptors, Melatonin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
